 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
9/27/23 Ligand Pharmaceuticals Inc. 8-K:5 9/22/23 10:146K
12/14/22 Ligand Pharmaceuticals Inc. 8-K:5 12/13/22 10:162K
12/5/22 Ligand Pharmaceuticals Inc. 8-K:5 12/5/22 10:166K
11/4/22 Ligand Pharmaceuticals Inc. 8-K:1,2,5,9 11/1/22 12:1.2M
8/2/22 Ligand Pharmaceuticals Inc. 8-K:5 7/29/22 10:162K
6/29/22 Ligand Pharmaceuticals Inc. 8-K:5,7,9 6/29/22 11:233K
6/13/22‡ Ligand Pharmaceuticals Inc. 8-K:5 6/10/22 10:199K
1/27/22 Ligand Pharmaceuticals Inc. 8-K:5 1/26/22 10:162K
7/14/21 Ligand Pharmaceuticals Inc. 8-K:5,7,8,9 7/12/21 11:233K
1/28/21 Ligand Pharmaceuticals Inc. 8-K:1,5 1/25/21 12:170K
12/16/20 Ligand Pharmaceuticals Inc. 8-K:5 12/15/20 12:180K
12/23/19 Ligand Pharmaceuticals Inc. 8-K:5 12/20/19 10:144K Donnelley … Solutions/FA
10/16/19 Ligand Pharmaceuticals Inc. 8-K:5,7,9 10/15/19 13:245K
6/10/19 Ligand Pharmaceuticals Inc. 8-K:5 6/6/19 1:66K
1/25/19 Ligand Pharmaceuticals Inc. 8-K:5 1/23/19 1:26K
1/29/18 Ligand Pharmaceuticals Inc. 8-K:5 1/29/18 1:33K
8/21/17 Ligand Pharmaceuticals Inc. 8-K:5,7 8/18/17 2:402K
1/27/17 Ligand Pharmaceuticals Inc. 8-K:5 1/27/17 1:22K
9/22/16 Ligand Pharmaceuticals Inc. 8-K:5 9/22/16 1:24K
5/25/16 Ligand Pharmaceuticals Inc. 8-K:5 5/23/16 1:30K Donnelley … Solutions/FA
| ____________ | | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | | ¹ | Filing/Form Type: -D | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|
